{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:37:26Z","timestamp":1790674646992,"version":"4.1.0"},"reference-count":92,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Inherited blood disorders comprise a large spectrum of diseases due to germline mutations in genes with key function in the hematopoietic system; they include immunodeficiencies, anemia or metabolic diseases. For most of them the only curative treatment is bone marrow transplantation, a procedure associated to severe complications; other therapies include red blood cell and platelet transfusions, which are dependent on donor availability. An alternative option is gene therapy, in which the wild-type form of the mutated gene is delivered into autologous hematopoietic stem cells using viral vectors. A more recent therapeutic perspective is gene correction through CRISPR\/Cas9-mediated gene editing, that overcomes safety concerns due to insertional mutagenesis and allows correction of base substitutions in large size genes difficult to incorporate into vectors. However, applying this technique to genomic disorders caused by large gene deletions is challenging. Chromosomal transplantation has been proposed as a solution, using a universal source of wild-type chromosomes as donor, and induced pluripotent stem cells (iPSCs) as acceptor. One of the obstacles to be addressed for translating PSC research into clinical practice is the still unsatisfactory differentiation into transplantable hematopoietic stem or mature cells. We provide an overview of the recent progresses in this field and discuss challenges and potential of iPSC-based therapies for the treatment of inherited blood disorders.<\/jats:p>","DOI":"10.3390\/cells11030557","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T20:36:47Z","timestamp":1644179807000},"page":"557","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-2957","authenticated-orcid":false,"given":"Ilaria","family":"Rao","sequence":"first","affiliation":[{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crisafulli","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy"},{"name":"UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-9982","authenticated-orcid":false,"given":"Marianna","family":"Paulis","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy"},{"name":"UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-1189","authenticated-orcid":false,"given":"Francesca","family":"Ficara","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy"},{"name":"UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ymthe.2017.03.024","article-title":"Gene Therapy for \u03b2-Hemoglobinopathies","volume":"25","author":"Cavazzana","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Rojas","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajhg.2009.03.010","article-title":"DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources","volume":"84","author":"Firth","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/sctm.20-0247","article-title":"Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives","volume":"9","author":"Demirci","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13287-020-01998-9","article-title":"Differentiation of human induced pluripotent stem cells into erythroid cells","volume":"11","author":"Ebrahimi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/bloodadvances.2020003236","article-title":"Transfer to the clinic: Refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors","volume":"5","author":"Evans","year":"2021","journal-title":"Blood Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2012-03-420703","article-title":"Zinc-finger nuclease-mediated correction of \u03b1-thalassemia in iPS cells","volume":"120","author":"Chang","year":"2012","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/stem.1969","article-title":"Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation","volume":"33","author":"Huang","year":"2015","journal-title":"Stem Cells"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1160\/TH14-06-0503","article-title":"Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation","volume":"113","author":"Ingrungruanglert","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.stem.2015.02.005","article-title":"Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs","volume":"16","author":"Menon","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.stemcr.2016.06.003","article-title":"Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects","volume":"7","author":"Laskowski","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.1038\/srep18865","article-title":"In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_16","first-page":"135","article-title":"Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells","volume":"32","author":"He","year":"2017","journal-title":"Chin. Med. Sci. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13287-018-0839-8","article-title":"Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system","volume":"9","author":"Lyu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","article-title":"Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia, A","volume":"11","author":"Olgasi","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13287-018-0779-3","article-title":"One-step genetic correction of hemoglobin E\/beta-thalassemia patient-derived iPSCs by the CRISPR\/Cas9 system","volume":"9","author":"Wattanapanitch","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature13551","article-title":"Abnormalities in human pluripotent cells due to reprogramming mechanisms","volume":"511","author":"Ma","year":"2014","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dvg.22835","article-title":"Off-target assessment of CRISPR-Cas9 guiding RNAs in human iPS and mouse ES cells","volume":"53","author":"Tan","year":"2015","journal-title":"Genesis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35218","DOI":"10.18632\/oncotarget.6143","article-title":"Chromosome transplantation as a novel approach for correcting complex genomic disorders","volume":"6","author":"Paulis","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtm.2020.01.003","article-title":"Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders","volume":"17","author":"Paulis","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-019-0578-x","article-title":"Human iPSC banking: Barriers and opportunities","volume":"26","author":"Huang","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stemcr.2020.07.009","article-title":"Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells","volume":"15","author":"Tursky","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/EBC20170053","article-title":"The genetic basis of disease","volume":"62","author":"Jackson","year":"2018","journal-title":"Essays Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1086\/301874","article-title":"X-Linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase","volume":"62","author":"Rae","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-015-9113-x","article-title":"Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms","volume":"7","author":"Guna","year":"2015","journal-title":"J. Neurodev. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5581\/1516-8484.20110037","article-title":"Hematological abnormalities and 22q11.2 deletion syndrome","volume":"33","author":"Rosa","year":"2011","journal-title":"Rev. Bras. Hematol Hemoter."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: An intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","article-title":"The Fanconi anaemia pathway: New players and new functions","volume":"17","author":"Ceccaldi","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/br.2021.1450","article-title":"An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches (Review)","volume":"15","author":"Moreno","year":"2021","journal-title":"Biomed. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1086\/302627","article-title":"High frequency of large intragenic deletions in the Fanconi anemia group A gene","volume":"65","author":"Morgan","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3324\/haematol.2014.104224","article-title":"Molecular analysis of Fanconi anemia: The experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology","volume":"99","author":"Bottega","year":"2014","journal-title":"Haematologica"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3389\/fimmu.2020.02001","article-title":"Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia","volume":"11","author":"Yeh","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10875-007-9123-x","article-title":"Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes","volume":"27","author":"Smith","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xiang, Y., and Sugimura, R. (2021). Single-Cell Approaches to Deconvolute the Development of HSCs. Cells, 10.","DOI":"10.3390\/cells10112876"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/cr.2012.23","article-title":"Genetic correction of \u03b2-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice","volume":"22","author":"Wang","year":"2012","journal-title":"Cell Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/stem.1436","article-title":"Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted \u03b2-thalassemia patient","volume":"31","author":"Tubsuwan","year":"2013","journal-title":"Stem Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJMc1706274","article-title":"Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration","volume":"377","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stemcr.2015.08.005","article-title":"Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts","volume":"5","author":"Neri","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.154","article-title":"Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs","volume":"24","author":"Laugsch","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.celrep.2015.08.013","article-title":"Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR\/Cas9-Enhanced Gene Targeting","volume":"12","author":"Chang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/mt.2014.195","article-title":"An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease","volume":"23","author":"Merling","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.stemcr.2021.10.017","article-title":"Simultaneous high-efficiency base editing and reprogramming of patient fibroblasts","volume":"16","author":"Jalil","year":"2021","journal-title":"Stem Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Wiebking","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Salisbury-Ruf, C.T., and Larochelle, A. (2021). Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030513"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.stem.2019.10.004","article-title":"In Vivo Selection for Gene-Corrected HSPCs Advances Gene Therapy for a Rare Stem Cell Disease","volume":"25","author":"Gentner","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1089\/scd.2016.0149","article-title":"CRISPR\/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia","volume":"25","author":"Osborn","year":"2016","journal-title":"Stem Cells Dev."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Skvarova Kramarzova, K., Osborn, M.J., Webber, B.R., DeFeo, A.P., McElroy, A.N., Kim, C.J., and Tolar, J. (2017). CRISPR\/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061269"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3324\/haematol.2019.238261","article-title":"Expanded circulating hematopoietic stem\/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis","volume":"106","author":"Capo","year":"2021","journal-title":"Haematologica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/stem.3006","article-title":"Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells","volume":"37","author":"Castelli","year":"2019","journal-title":"Stem Cells"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1002\/1873-3468.12389","article-title":"Origin of the hematopoietic system in the human embryo","volume":"590","author":"Julien","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1002\/1873-3468.13599","article-title":"Human-induced pluripotent stem cell-derived blood products: State of the art and future directions","volume":"593","author":"Hansen","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stemcr.2016.12.020","article-title":"Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages","volume":"8","author":"Buchrieser","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2016-11-749382","article-title":"Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4","volume":"129","author":"Creamer","year":"2017","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1089\/scd.2014.0318","article-title":"Human induced pluripotent stem cell-derived B lymphocytes express sIgM and can be generated via a hemogenic endothelium intermediate","volume":"24","author":"French","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.devcel.2017.12.005","article-title":"A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1","volume":"44","author":"Richardson","year":"2018","journal-title":"Dev. Cell."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Wu, B., Weng, Q., Hu, F., Lin, Y., Xia, C., Peng, H., Wang, Y., Liu 1, X., and Liu, L. (2021). Regeneration of immunocompetent B lymphopoiesis from pluripotent stem cells guided by transcription factors. Cell Mol. Immunol.","DOI":"10.1038\/s41423-021-00805-6"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41422-019-0251-7","article-title":"Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factors","volume":"30","author":"Guo","year":"2020","journal-title":"Cell Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","article-title":"Haematopoietic stem and progenitor cells from human pluripotent stem cells","volume":"545","author":"Sugimura","year":"2017","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stemcr.2020.05.019","article-title":"Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential","volume":"15","author":"Lange","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.15252\/emmm.201505301","article-title":"Lost in translation: Pluripotent stem cell-derived hematopoiesis","volume":"7","author":"Ackermann","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ncb3419","article-title":"Progress towards generation of human haematopoietic stem cells","volume":"18","author":"Wahlster","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4939-1133-2_12","article-title":"Hematopoietic differentiation of pluripotent stem cells in culture","volume":"1185","author":"Mills","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","article-title":"Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures","volume":"108","author":"Vodyanik","year":"2006","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.stem.2008.06.001","article-title":"Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches","volume":"3","author":"Ledran","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2012.11.003","article-title":"T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures","volume":"2","author":"Kennedy","year":"2012","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"101600","DOI":"10.1016\/j.scr.2019.101600","article-title":"Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system","volume":"41","author":"Ruiz","year":"2019","journal-title":"Stem Cell Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mora-Roldan, G.A., Ramirez-Ramirez, D., Pelayo, R., and Gazarian, K. (2021). Assessment of the Hematopoietic Differentiation Potential of Human Pluripotent Stem Cells in 2D and 3D Culture Systems. Cells, 10.","DOI":"10.3390\/cells10112858"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nbt.2915","article-title":"Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells","volume":"32","author":"Sturgeon","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.xpro.2020.100130","article-title":"Protocol for the Generation of Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells","volume":"1","author":"Nafria","year":"2020","journal-title":"STAR Protoc."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100367","DOI":"10.1016\/j.xpro.2021.100367","article-title":"differentiation of human embryonic stem cells to hemogenic endothelium and blood progenitors via embryoid body formation","volume":"2","author":"Potts","year":"2021","journal-title":"STAR Protoc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1182\/blood-2007-10-117622","article-title":"Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors","volume":"111","author":"Takayama","year":"2008","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.stem.2019.04.001","article-title":"Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination","volume":"24","author":"Martin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cell.2020.10.018","article-title":"Defining the Teratoma as a Model for Multi-lineage Human Development","volume":"183","author":"McDonald","year":"2020","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.stemcr.2017.08.010","article-title":"In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma","volume":"9","author":"Tsukada","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_84","first-page":"194","article-title":"Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice","volume":"1","author":"Deng","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.stemcr.2015.10.002","article-title":"Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells","volume":"5","author":"Garate","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1111\/jcmm.16872","article-title":"Generation of \u2018designer erythroblasts\u2019 lacking one or more blood group systems from CRISPR\/Cas9 gene-edited human-induced pluripotent stem cells","volume":"25","author":"Pandey","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1359\/jbmr.090715","article-title":"Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis","volume":"25","author":"Cappariello","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1182\/bloodadvances.2021004552","article-title":"Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood","volume":"5","author":"Root","year":"2021","journal-title":"Blood Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"101660","DOI":"10.1016\/j.scr.2019.101660","article-title":"Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene","volume":"42","author":"Lanzi","year":"2020","journal-title":"Stem Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2106\/JBJS.19.00558","article-title":"TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis","volume":"101","author":"Chen","year":"2019","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13287-020-01701-y","article-title":"Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells","volume":"11","author":"Xian","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.bonr.2020.100242","article-title":"Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis","volume":"12","author":"Palagano","year":"2020","journal-title":"Bone Rep."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/557\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:14:36Z","timestamp":1760134476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":92,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11030557"],"URL":"https:\/\/doi.org\/10.3390\/cells11030557","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]}}}